510(k) K860228
K860228 is an FDA 510(k) premarket notification submitted by Boots-Celltech Diagnostics, Inc. for the device "SUCROSEP HUMAN GROWTH HORMONE (HGH) IRMA". The FDA issued a decision of Substantially Equivalent on February 28, 1986. The device falls under product code CFL (Radioimmunoassay, Human Growth Hormone), a Class I device regulated under 21 CFR 862.1370. Boots-Celltech Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 28, 1986
- Date Received
- January 22, 1986
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Human Growth Hormone
- Device Class
- Class I
- Regulation Number
- 862.1370
- Review Panel
- CH
- Submission Type